Title: Research Communications of the 24th ECVIM-CA Congress Document date: 2015_1_10
ID: r59usk02_273
Snippet: To conclude, the DLBCL displayed a good clinical response to L-COP protocol, with a median survival time of 311 days. The only significant prognostic criterion identified was a complete clinical response to the treatment. A prospective controlled study on a larger population is warranted to confirm these results......
Document: To conclude, the DLBCL displayed a good clinical response to L-COP protocol, with a median survival time of 311 days. The only significant prognostic criterion identified was a complete clinical response to the treatment. A prospective controlled study on a larger population is warranted to confirm these results.
Search related documents:
Co phrase search for related documents- clinical response and control study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- clinical response and survival time: 1, 2
- clinical response and treatment clinical response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- complete treatment clinical response and treatment clinical response: 1, 2, 3
- control study and large population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
- control study and large population control study: 1
- control study and result confirm: 1
- control study and survival time: 1, 2, 3, 4, 5, 6, 7, 8
- control study and treatment clinical response: 1, 2, 3
- large population and survival time: 1, 2
Co phrase search for related documents, hyperlinks ordered by date